Cagent Vascular received FDA 510(k) clearance of its Serranator PTA Serration balloon catheter for treating below-the-knee (BTK) lesions. The Serranator angioplasty balloon device is FDA cleared and CE marked, embedding serration technology into a semi-compliant balloon for treating peripheral artery disease (PAD). It’s designed to create multiple longitudinal lines of interrupted micro-serrations to aid arterial expansion.
Explore the July 2020 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Children’s National, FDA collaborate to advance pediatric device regulatory tools
- LK Metrology’s eco-friendliness CMMs
- Two patents for microfluidic valves
- AMADA WELD TECH’s blue diode laser technology
- Post-IMTS decline in manufacturing technology orders blunted
- ARS Automation’s FlexiBowl 200
- LMA Consulting urges businesses to restructure supply chains now
- Walter’s WEP01C indexable inserts